.
Lichtenberg, Frank R.'s
Scholarly Papers
Click on the title of any column to sort the table by that
column.
Aggregate Statistics
Total Downloads
4,088
Total
Citations
500
1.
The Benefits and Costs of Newer Drugs: Evidence From the 1996 Medical Expenditure Panel Survey
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Posted:
08 Mar 01
Last Revised:
11 Aug 04
403
(33,752)
6
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
163
6
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
240
6
2.
The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Kim, Moshe University of Haifa - Department of Economics
Posted:
27 Oct 99
Last Revised:
27 Jul 11
345
(40,867)
1
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Kim, Moshe University of Haifa - Department of Economics
22
1
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Kim, Moshe University of Haifa - Department of Economics
323
1
3.
Sources of U.S. Longevity Increase, 1960 - 1997
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Posted:
21 Mar 01
Last Revised:
11 Aug 04
316
(45,374)
20
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
55
20
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
261
20
4.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
207
(72,257)
home health care, hospitals, length of stay
5.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
198
(75,534)
4
6.
Industrial De-Diversification and its Consequences for Productivity
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Posted:
15 Mar 00
Last Revised:
27 Jul 11
186
(80,325)
22
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
14
22
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
172
22
7.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
147
(99,703)
20
8.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
114
(122,943)
9.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Siegel, Donald S. University at Albany, SUNY
107
(128,931)
77
10.
The Allocation of Publicly-Funded Biomedical Research
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Posted:
09 Dec 97
Last Revised:
27 Jul 11
105
(130,690)
5
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
31
5
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
74
5
11.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
96
(139,030)
1
12.
Pharmaceutical Price Discrimination and Social Welfare
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Posted:
26 Oct 11
Last Revised:
15 Apr 13
91
(144,128)
2
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
21
2
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
70
2
13.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Waldfogel, Joel University of Minnesota - Twin Cities - Carlson School of Management
78
(158,827)
7
14.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
78
(158,827)
18
15.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Virabhak, Suchin affiliation not provided to SSRN
75
(162,705)
14
16.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
73
(165,314)
orphan drugs, rare diseases, mortality, innovation
17.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Pushner, George M. University of New Haven
70
(169,414)
27
18.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Pettersson, Billie affiliation not provided to SSRN
68
(172,148)
longevity, pharmaceutical, innovation, drugs, Sweden
19.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
67
(173,545)
6
20.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
66
(174,931)
1
21.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
62
(180,781)
24
22.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
van Pottelsberghe de la Potterie, Bruno Free University of Brussels - Solvay Business School
57
(188,656)
10
23.
The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Posted:
14 Nov 04
Last Revised:
26 Oct 11
54
(193,643)
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
11
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
43
24.
Griliches, Zvi Deceased
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
54
(193,643)
25.
Akkoyunlu, Sule KOF Swiss Economic Institute
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Siliverstovs, Boriss German Institute for Economic Research (DIW Berlin) - Department of International Economics
Zweifel, Peter University of Zurich - Department of Economics Library
53
(195,292)
health, life expectancy, innovation, pharmaceuticals, health care expenditure, cointegration
26.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
53
(195,292)
2
27.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Siegel, Donald S. University at Albany, SUNY
51
(198,748)
37
28.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
50
(200,505)
1
29.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
48
(204,216)
30.
The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the Us Pharmaceuticals Industry
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Philipson, Tomas University of Chicago
Posted:
07 Nov 02
Last Revised:
27 Jul 11
46
(207,940)
12
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Philipson, Tomas University of Chicago
0
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Philipson, Tomas University of Chicago
46
12
31.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
42
(215,829)
1
32.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
42
(215,829)
38
33.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
41
(217,855)
1
34.
Lehr, William Massachusetts Institute of Technology (MIT)
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
39
(221,995)
5
35.
Lleras-Muney, Adriana Princeton University - Woodrow Wilson School of Public and International Affairs
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
36
(228,589)
18
36.
Freund, Deborah Claremont Colleges - Claremont Graduate University
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
35
(230,915)
37.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
34
(233,294)
38.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
32
(238,087)
39.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
30
(243,365)
1
40.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
29
(246,109)
longevity, innovation, pharmaceuticals, obesity
41.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
27
(251,969)
2
42.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
26
(258,216)
43.
Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Posted:
07 Jun 10
Last Revised:
26 Oct 11
26
(255,093)
1
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
8
1
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
18
1
44.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
23
(264,982)
45.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Siegel, Donald S. University at Albany, SUNY
22
(268,387)
24
46.
Bartel, Ann P. Columbia Business School - Finance and Economics
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
22
(268,387)
67
47.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
22
(268,387)
2
48.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
19
(278,834)
5
49.
Feldman, Maryann P. University of North Carolina at Chapel Hill
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
19
(278,834)
6
50.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
19
(278,834)
51.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
18
(282,364)
4
52.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Griliches, Zvi Deceased
16
(289,547)
5
53.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Duflos, Gautier University of Paris 1 Pantheon-Sorbonne
12
(303,762)
1
54.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
10
(310,502)
1
55.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
7
(319,747)
56.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
6
(322,614)
57.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
6
(322,614)
58.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
5
(325,291)
59.
Bartel, Ann P. Columbia Business School - Finance and Economics
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
3
(331,194)
1
60.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
2
(335,975)
61.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Imitation, Hatch-Waxman Act of 1984, U.S. Food & Drug Administration (FDA), Kefauver-Harris Amendment of 1962, Prescription Drug User Fee Act of 1992, Medicare, Medicaid, Industrial research, Federal regulations, Product development, Public policies, R&D expenditures, Healthcare industry, Policy analysis, Innovation process, Market value, Patents, Pharmaceutical industry
62.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Jonsson, Bengt Uppsala University - Department of Information Science
Wilking, Nils affiliation not provided to SSRN
cancer, pharmaceutical, innovation
63.
Lichtenberg, Frank R. Columbia Business School - Finance and Economics
Health, HIV, mortality, new drug approvals